The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000152.4(GAA):c.989G>A (p.Trp330Ter)

CA401364487

550355 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: 9f5cddfd-829f-4b18-bcac-a5752aaa7335
Approved on: 2020-04-21
Published on: 2020-05-27

HGVS expressions

NM_000152.4:c.989G>A
NM_000152.4(GAA):c.989G>A (p.Trp330Ter)
NM_000152.3:c.989G>A
NM_001079803.1:c.989G>A
NM_001079804.1:c.989G>A
NM_001079803.2:c.989G>A
NM_001079804.2:c.989G>A
NM_000152.5:c.989G>A
NM_001079803.3:c.989G>A
NM_001079804.3:c.989G>A
ENST00000302262.7:c.989G>A
ENST00000390015.7:c.989G>A
NC_000017.11:g.80108323G>A
CM000679.2:g.80108323G>A
NC_000017.10:g.78082122G>A
CM000679.1:g.78082122G>A
NC_000017.9:g.75696717G>A
NG_009822.1:g.11768G>A
More

Pathogenic

Met criteria codes 3
PP4 PM2 PVS1
Not Met criteria codes 1
PM3

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
This variant, c.989G>A (p.Trp330Ter), is a nonsense variant that is predicted to result in nonsense mediated decay and lack of gene product, meeting PVS1. Two individuals with Pompe disease and meeting the ClinGen LSD VCEP's specifications for PP4 have been reported in the literature. These individuals are non-identical twins and are compound heterozyous for the variant and c.1655T>C (p.Leu552Pro); this in trans data was used in the assessment of p.Leu552Pro and therefore was not included here in order to avoid a circular argument. Another individual was reported to be compound heterozygous for the variant and c.-32-13T>G (PMID 29880332). While this patient was described as having reduced GAA activity in dried blood spots, the normal range for the assay was not provided and therefore this data was not included. The variant is absent in gnomAD v2.1.1, meeting PM2. There is a ClinVar entry for this variant (Variation ID 550355; 1 star review status) with one submitter classifying the variant as likely pathogenic. In summary, the variant meets the criteria to be classified as pathogenic for Pompe disease. ACMG-AMP criteria met, based on the specifications of the ClinGen LSD VCEP: PVS1, PM2, PP4.
Met criteria codes
PP4
Non-identical twins have been reported who are compound heterozygous for the variant and have absent GAA activity in fibroblasts (PMID 12923862), meeting PP4.

PM2
This variant is absent in gnomAD v2.1.1.
PVS1
This is a nonsense variant which is predicted to cause nonsense mediated decay resulting in lack of gene product.
Not Met criteria codes
PM3
Two individuals with Pompe disease and meeting the ClinGen LSD VCEP's specifications for PP4 have been reported in the literature. These individuals are non-identical twins and are compound heterozyous for the variant and c.1655T>C (p.Leu552Pro); this in trans data was used in the assessment of p.Leu552Pro and therefore was not included here in order to avoid a circular argument. Another individual was reported to be compound heterozygous for the variant and c.-32-13T>G (PMID 29880332). While this patient was described as having reduced GAA activity in dried blood spots, the normal range for the assay was not provided and therefore this data was not included.

Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.